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Abstract in English 
Health expenditure as a share of GDP rises in most OECD countries. One of the possible causes 
is the so-called Baumol effect, which may arise if labour productivity in health care grows more 
slowly than in the overall economy. If in addition demand for health care is inelastic, then the 
share of health spending in GDP will rise over time. This paper estimates the Baumol effect in 
health spending, using a panel data set of OECD countries. We do indeed find that one 
percentage growth in economy-wide labour productivity is associated with about 0.5 percent 
growth in real health spending. This implies that economy-wide productivity growth leads to 
higher real health spending.  
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Abstract in Dutch 
Het aandeel van de zorguitgaven in het BBP stijgt in de meeste OESO-landen. Een mogelijke 
oorzaak is het zogenoemde Baumol-effect, dat optreedt indien de arbeidsproductiviteit in de 
zorg langzamer stijgt dan in de rest van de economie. Als bovendien de vraag naar zorg 
inelastisch is, dan neemt het aandeel van de zorguitgaven in het BBP toe. Dit paper presenteert 
schattingen van het Baumol-effect in de zorg op basis van paneldata van OESO-landen. We 
vinden dat 1 procent arbeidsproductiviteitsgroei in de economie als geheel gepaard gaat met 0,5 
procent groei van de reële zorguitgaven. Dit betekent dat arbeidsproductiviteitsgroei in de 
economie als geheel leidt tot hogere zorguitgaven.  
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Summary 
Health expenditure as a share of GDP rises in most OECD countries. One of the possible causes 
is the so-called Baumol effect, which may arise if labour productivity in health care grows more 
slowly than in the overall economy. If in addition demand for health care is inelastic, then the 
share of health spending in GDP will rise over time. This paper estimates the Baumol effect in 
health spending, using a panel data set of OECD countries. We will attempt to answer two 
questions: 
 
1.  How large is the Baumol effect in health care? 
2.  What does the estimated Baumol effect tell us about cost-reducing technological change in 
health care? 
 
These questions will be answered by regressing real health spending on economy-wide 
productivity growth (GDP per hour worked), controlling for GDP per capita. If a Baumol effect 
is present in health spending, then we would expect that economy-wide productivity growth 
leads to higher real health spending. We do indeed find a sizeable Baumol effect: one 
percentage growth in economy-wide labour productivity is associated to with about 0.5 percent 
growth in real health spending. In addition, we find plausible values for the effect of real 
income growth on health spending, consistent with income elasticities for health spending 
reported in the literature. We infer from the estimation results that labour productivity growth in 
health care was 0.2 to 0.4 times as large as labour productivity growth in the economy as a 
whole. 
 
   9 
1  Background 
New medical technology is widely seen as a major (if not the main) driver of health spending 
(e.g. OECD 2006). If this view is correct, then cost-reducing new technology must have been 
less important than new medical technology that has resulted in the treatment expansion: 
treatment of hitherto untreated diseases or better (but more expensive) treatment of diseases that 
could already be treated.  
The consensus view that new medical technology has on net led to higher spending is based 
on decompositions of past health spending; Newhouse (1992) is the classic reference. In this 
decomposition approach, one first determines the share of the increase in health spending that 
can be explained by measurable factors such as income growth. The unexplained residual is 
then attributed to technological change. Whether such a ‘residual approach’ leads to correct 
results depends critically on whether all relevant factors other than technology have been taken 
into account. Otherwise, the residual would be ‘polluted’ by omitted variables. Tellingly, 
Ambramovitz, the pioneer of residual analysis in growth economics, labelled the residual a 
measure of our ignorance. 
Recent micro-economic evidence suggests that cost-reducing technological progress plays a 
significant role in health care. In particular, the work of Lichtenberg (2007) suggests that each 
dollar spent on new pharmaceuticals leads to 4 dollars in cost savings elsewhere in the health 
system. This implies that at least this type of technological progress has been expenditure 
reducing rather than expenditure increasing.  
If technological progress has mainly resulted in treatment expansion rather than cost 
savings, then we would expect to find a sizeable Baumol effect in health spending: productivity 
growth in the rest of the economy should then lead to a higher relative price of health care and 
hence (given that demand for health care is price-inelastic), higher real spending on health. 
Conversely, if Lichtenberg’s findings are representative of health care more broadly (i.e. rapid 
cost-saving technological progress), then the Baumol effect in health spending must be small.  
Empirically there is strong evidence for the presence of Baumol effects. For example, 
Nordhaus (2006) uses detailed data on economic activity by industry to analyse different 
Baumol-type diseases. One of the questions he poses is whether low relative productivity 
growth leads to high relative price increases. Using different industry combinations, Nordhaus 
(2006) regresses average annual logarithmic change in price on a measure of the annual 
logarithmic change in productivity. The hypothesis of a cost-price disease due to slow 
productivity growth is strongly supported - industries with relatively lower productivity growth 
show a percentage-point for percentage-point higher growth in relative prices.  
In this paper, we focus on the Baumol effect in health spending, using a panel data set of 
OECD countries. We will attempt to answer two questions: 
   10 
1.  How large is the Baumol effect in health care? 
2.  What does the estimated Baumol effect tell us about the amount cost-reducing technological 
change in health care? 
 
These questions will be answered by regressing real health spending on economy wide 
productivity growth (GDP per hour worked), controlling for GDP per capita. The estimated 
coefficient tells us to what extent economy-wide productivity growth leads to higher real health 
spending. If the Baumol effect is an important driver of higher health spending, then this 
coefficient should be large (close to unity). If the Baumol effect is unimportant (i.e. if cost-
reducing technological progress has been substantial) in health care, then the estimated 
coefficient should be small (close to zero).  
The paper is structured as follows. The next section presents the theoretical model. Section 3 
discusses the data, while section 4 presents estimation results. Section 5 combines the 
estimation results with information on non-technological determinants of health spending in 
order to infer the rate of labour saving technological progress in health care. Section 6 
concludes.   11 
2  The Theoretical Model 
In this section, we present the theoretical model, which is used as a starting point for our 
econometric analysis and for the inferences that will be drawn from these estimates.  
Changes in nominal health spending may be decomposed into changes in prices and changes 
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where  
 
H     =  nominal health spending 
H H / ∆    =  rate of change in nominal health spending over time 
Q     =   the volume of health services consumed 
Q Q/ ∆     =  rate of change in health volume over time 
h P     =   price of health services 
h h P P / ∆   =   nominal rate of change in price of health services at constant quality 
 
In what follows, we ignore the last term in equation (1), which will be small for small changes 
in price and volume.  
It is important to stress that quality changes are included in Q, so that  h h P P / ∆  captures 
price increases at constant quality. Thus Q Q/ ∆ is a hedonic index of the growth in health 
volume.  Empirically it is very hard to make this type of price/volume split (Newhouse, 1992). 
As a consequence, price increases in health care are often contaminated by quality increases 
(Cutler en Berndt (2001)). The main reason is that it is hard to measure and value quality 
improvements in health care. This is the main cause of the uncertainty surrounding the effects 
of technological progress on health spending. One of the advantages of our approach is that we 
do not need to empirically make a volume/price split.  
We assume that changes in health volume, including changes in quality, are determined by 




















h                                                                                                           (2) 
 
where Z is a vector including the determinants of the volume of health spending other than price 
(e.g. an exogenous trend, growth in real income, demographic changes, etc.), g is a vector of 
coefficients (including the income elasticity of demand for health care) and h is the price 
elasticity of demand for health care ( 0 < h ).  
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We model the change in the price of health as follows. First, at a given state of technology, 
economy-wide price inflation will translate one to one into health prices, still measured at 
constant quality. Second, according to  Baumol’s law, lower labour productivity growth in 
health care translates into an additional price increase in health. This is because economy-wide 
labour productivity growth translates one to one into wages (below we will present empirical 
evidence corroborating this statement). In order to keep and attract workers, wages in the health 
care sector will have to keep up with economy wide wages. As a result, the relative price of 
health services will go up. If we assume that the productivity of factors of production other than 
labour grows at the same rate in health care as in the rest of the economy, then the excess price 
increase in health services depends only on the labour share of health services. Denoting the 































P P/ ∆     =   economy-wide rate of inflation (captured by the GDP deflator) 
A A/ ∆     =  rate of productivity growth in the economy as a whole 
h h A A / ∆   =  rate of productivity growth in health care 
b    =  labour share in health 
 
Equation (3) says that price inflation in health equals economy wide inflation plus a Baumol 
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We define the ratio of labour productivity growth in health services to labour productivity 
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Substitution of (5) into (4) yields:  
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Equation (6) will be the basis for our econometric analysis. We will estimate variants of the 
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This yields an estimate for δ. We can combine the estimate for δ with exogenous information on 
b (the labour share in health care) and h (the price elasticity of demand for health care) in order 
to compute k in equation (6):  
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Significance tests for k* are based on the standard error of δ using the delta method. For the 
standard error of  k* we have:  
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3  Data 
We explore two data sources in the empirical analysis. The data on health expenditures are 
extracted from the OECD Health Data Base 2006, as well as gross domestic product (GDP) per 
capita, and population age 65 and over. The health expenditures are measured as the total health 
expenditures per capita, expressed in the National Currency Units (NCU)
1 at 2000 GDP price 
levels. GDP per capita series is also expressed in the NCU at 2000 GDP price levels. Population 
age 65 and over is expressed as a percentage of total population. 
From the Groningen Growth & Development Centre (GGDC), we extract GDP per capita 
and GDP per hour worked (which is equivalent to labour productivity in the economy) series. 
Both series are expressed in 2006 US dollars, converted to 2006 price level with updated 2002 
EKS
2 PPPs. GDP per capita is available for 42, while GDP per hour worked is available for 38 
OECD and (candidate) EU member countries, plus Israel.  
All series are extracted in the period 1970 to 2004, for the following sample of the OECD 
countries: Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, 
Iceland, Ireland, Italy, Japan, Luxembourg, Netherlands, New Zealand, Norway, Portugal, 
Spain, Sweden, Switzerland, United Kingdom and United States (23 in total)
3. We express all 
series in 2006 US dollars, converted to 2006 price level with updated 2002 EKS PPPs
4. 
Summary statistics and correlations between analysed series are presented in Tables 3.1 and 3.2.  
As we can see from Table 3.1, we have an unbalanced panel of countries over the analysed 
time period (the largest sample size, if all observations are available, is 805). We can also see 
that GDP data from two sources (OECD & GGDC) have very similar summary statistics. From 
Table 3.2, we conclude that there exist high positive correlations between health expenditures 
and GDP per capita, GDP per hour worked, and population series. However, due to a very 
 
1 For the countries of the euro area (EMU), National Currency Units refer to national time series converted into euro by 
applying the irrevocable conversion rate between the national currency and the EUR. Thus, the evolution over time of all 
historical national series is preserved. It should, however, be noted that this conversion does not transform a national into an 
international currency. For international comparisons, data in NCU still need to be converted into purchasing power parity 
(PPP) transformed values.  
2 The EKS method is a multilateral method developed by O. Elteto, P. Koves, and B. Schultz that computes the n
th root of 
the product of all possible Fisher indexes between n countries. It has been used at the detailed heading level to obtain 
heading parities, and also at the GDP level. EKS has the properties of base-country invariance and transitivity. It is the 
method used by Eurostat and the OECD to calculate PPPs for basic headings and to aggregate basic heading PPPs to 
obtain PPPs for each level of aggregation up to and including GDP. Within the context of Eurostat-OECD comparisons, EKS 
results are considered to be better suited to comparisons across countries of the price and volume levels of individual 
aggregates. For more detailed definition, see the OECD glossary of statistical terms: 
http://stats.oecd.org/glossary/detail.asp?ID=5525 
3 We also estimate results for a smaller sample of 14 EU countries (Austria, Belgium, Denmark, Finland, France, Germany, 
Greece, Ireland, Italy, Netherlands, Portugal, Spain, Sweden, United Kingdom), plus the United States. See section 4 below.  
4 First, we convert series from the OECD data base expressed in NCU at 2000 GDP price levels, to a 2006 price base using 
OECD consumer price indices for 2006. Once series are expressed in 2006 prices, we divide them by the GDP PPPs 
available from the GGDC web site, in order to get all series in 2006 US dollars. Plots of the two GDP per capita series, one 
from the GGDC data base and the other from the OECD data base, both expressed in 2006 US dollars, are to be found in 
the Appendix.      16 
strong trendy behaviour of both health expenditures and GDP series
5, simply running an OLS 
regression would produce spurious estimation results. 
Table 3.1  Summary statistics: sample size, mean, standard deviation, min, and max 
Variable  Observation  Mean  Std. Dev.  Min  Max 
           
he  747  1931.57  889.36  226.63  6548.23 
gdph  786  31.80  9.59  10.96  61.84 
gdp
1
  805  24520  7227  8540  60080 
gdp
2
  786  24695  7558  8538  62076 
pop  801  13.27  2.42  7.1  19.5 
           
lhe  747  7.46  0.48  5.42  8.79 
lgdph  786  3.41  0.32  2.39  4.12 
lgdp
1
  805  10.06  0.30  9.05  11.00 
lgdp
2
  786  10.07  0.31  9.05  11.04 
lpop  801  2.57  0.19  1.96  2.97 
           
Note: he = health expenditures per capita; gdph = GDP per hour worked; gdp = GDP per capita (gdp
1
 = OECD source; gdp
2
 = GGDC 
source); pop = population age 65 and over; with prefix l for the ln transformation. 
 
Table 3.2  Correlation coefficients (series in levels and ln transformed) 
Variable  he  gdph  gdp
(1)  gdp
(2)  pop 
           
he  1.000         
gdph  0.741  1.000       
gdp
1
  0.858  0.853  1.000     
gdp
2
  0.822  0.888  0.986  1.000   
pop  0.375  0.541  0.361  0.393  1.000 
           
  lhe  lgdph  lgdp
(1)  lgdp
(2)  lpop 
           
lhe  1.000         
lgdph  0.822  1.000       
lgdp
1
  0.909  0.874  1.000     
lgdp
2
  0.887  0.907  0.988  1.000   
Lpop  0.452  0.579  0.404  0.449  1.000 
           
Note: he = health expenditures per capita; gdph = GDP per hour worked; gdp = GDP per capita (gdp
1
 = OECD source; gdp
2
 = GGDC 
source); pop = population age 65 and over; with prefix l for the ln transformation. 
 
 
5 Graphs of the analysed series are presented in the Appendix.   17 
4  Estimation results 
Following the approach of the recent paper by Lichtenberg (2007), we estimate equation (7) in 




it i it it it Z A H ε α γ β + + + = ln ln ln                                                                                          (11)   
where  it H  is a natural logarithm of health expenditures per capita in a country i, in a year t;  it A  
is a natural logarithm of the GDP per hour worked and it is a measure of labour productivity in 
the economy as a whole, in a country i, in a year t;  it Z  is a vector of covariates, which consists 
of GDP per capita and population age 65 and over, in country i and year t;  i α captures 
unobserved country effects, and  it ε is a random error term. Estimation results of this first 
estimation approach are presented in Table 4.1. 
Table 4.1  Estimates of equation (11): all available years 
Variable  FE (1)  FE (2) (robust SEs)  FD (3)  FD (4) (robust SEs) 
         
lgdph  0.192  0.192     
  (0.070)***  (0.205)     
lgdp
2
  1.206  1.206     
  (0.072)***  (0.280)***     
lpop  0.458  0.458     
  (0.052)***  (0.280)     
dlgdph      0.499  0.499 
      (0.097)***  (0.157)*** 
dlgdp
2
      0.449  0.499 
      (0.093)***  (0.127)*** 
dlpop      0.788  0.788 
      (0.126)***  (0.146)*** 
         
Observations  725  725  695  695 
Number of countries  23  23     
         
Note: he = health expenditures per capita; gdph = GDP per hour worked; gdp = GDP per capita (gdp
2
 = GGDC source); pop = population 
age 65 and over; with prefix l for the ln transformation; with prefix d for the first-difference transformation; standard errors in parentheses; 
* p<0.1; ** p<0.05;
 *** p<0.01. 
 
Table 4.1 shows in columns (1) and (2) the within estimation results (FE) of equation (11), 
without and with robust standard errors
6; columns (3) and (4) show OLS estimation results of 
equation (11) expressed in first differences (FD), without and with robust standard errors. If our 
model is correctly specified, the within and the ‘first-difference’ estimation procedures should 
yield similar estimates for the parameters  β  and γ  (Verbeek, 2004). The only difference 
should be in the estimated standard errors.  
 
6 Newey-West standard errors.   18 
The error term of equation (11) might follow a first-order autoregressive process: 
 
it it it u u ξ ρ + = −1  
 
where  it ξ  is a white noise term. We performed Breusch-Godfrey test on autocorrelation, which 
tests the following hypothesis  0 : 0 = ρ H . However, we cannot reject  0 H  of no autocorrelation 
in the error term, either for the within or the model in first differences. Nevertheless, we re-
estimated both models with robust standard errors, which are robust to the presence of both 
autocorrelation and heteroscedasticity.  
Our estimated robust standard errors are larger than the non-robust ones, which usually 
indicates that there is a slight positive autocorrelation in the error term. Further, our estimates of 
β  and γ  are dramatically different between the within and the ‘first-difference’ estimation 
procedures. This difference might be due to the omitted variable bias or to the fact that our 
exogenous variables are not strictly exogenous.  
 
We also follow the second approach of Lichtenberg (2007), and estimate equation (11) in the 
‘long-difference’ form (12): 
 
) ( ) ln (ln ) ln (ln ln ln ik iT ik iT ik iT ik iT Z Z A A H H ε ε γ β − + − + − = −                                      (12) 
 
where T and k correspond to different time periods in the sample. Since we base our estimation 
results on observations at the end of 17-, 10- and 5-year periods respectively, there cannot be 
serial correlation
7. Columns (1) to (3) in Table 4.2 show estimation results for different long-
difference periods.  In column (1), we have two observations per country
8, using data for  1 k  = 
1970 and  1 T  = 1987, and  2 k  = 1988 and  2 T  = 2004. Columns (2) and (3) show estimation 
results for 10- and 5-year long-difference periods respectively. 
 
7 Similar to the approach in Lichtenberg (2007) approach, we have also estimated equation (12) using data only for the first 
(k = 1970) and last (T = 2004) years of the sample period. However, due to the missing observations and a small number of 
countries, our sample shrinks to only 14 observations, rendering estimation impossible. 
8 The sample size is smaller than 46 due to missing observations for some years, for some countries, for some covariates.   19 
Table 4.2  Estimates of equation (12): 'long-difference' estimation procedure 
Variable  LD (1)  LD (2)  LD (3) 
       
  1970, 1987;   1970, 1979;  five-year periods 
  1988, 2004  1980, 1989;  1970, 1974; 
    1990, 1999; etc.   1975, 1979; etc. 
       
lgdph  0.308  0.600  0.462 
       
  (0.255)  (0.251)**  (0.140)*** 
lgdp
(2)  1.276  0.913  0.953 
  (0.279)***  (0.262)***  (0.139)*** 
Lpop  0.345  0.327  0.150 
  (0.256)  (0.207)  (0.186) 
Observations  32  75  135 
       
Note: he = health expenditures per capita; gdph = GDP per hour worked; gdp = GDP per capita (gdp
2
 = GGDC source); pop = population 
age 65 and over; with prefix l for the ln transformation; standard errors in parentheses; * p<0.1; ** p<0.05; *** p<0.01. 
 
Looking at the estimation results in columns (1) to (3) in Table 4.2, we conclude that labour 
productivity in the economy as a whole has a positive and significant effect on health 
expenditures per capita.  The size of this coefficient ranges from 0.3 (column 1) to 0.6 (column 
2). Since the sample size in column (1) is relatively small and the estimated coefficient on 
labour productivity is not significant, we believe that the size of this coefficient is between 0.5 
and 0.6. Comparing estimation results in Table 4.2 to the ‘first-difference’ estimation results in 
Table 4.1 (estimated coefficient for labour productivity is 0.5), the size of the estimated 
coefficient in Table 4.2 seems plausible.  
The estimated coefficient on GDP per capita is significant and around one (also for the 
smaller sample of countries), which is comparable to the estimation results of Mot and Van Elk 
(2007). However, our estimated standard errors are larger due to the small size of our sample. 
The estimated coefficient of population age 65 and over is not significant in all long-difference 
specifications (also for the smaller sample of countries).  
 
Checking our results for robustness, we re-estimated equations (11) and (12) using a smaller 
sample of countries (14 EU countries, plus USA), shortening the sample, so that we drop the 
first and last observations of the whole sample period (t = 1970 and t = 2004, respectively), and 
estimating results without France, Greece, and Italy. Explanation for the three additional sample 
specifications is as follows. First, 14 EU countries, plus USA are a more homogenous group of 
countries (in terms of GDP per capita) than full the sample of 23 OECD countries. Second, for 
some countries like Australia, Belgium, Denmark, Japan, Germany and the Netherlands, data on 
health expenditures are missing at the first and/or the last observations. Third, France, Greece, 
and Italy have large chunks of health expenditure data missing.  
The robustness checks are presented in the Appendix. The estimated results for all three 
sample specifications are robust if we look at the ‘first-difference’ estimations in Tables 8.1, 
8.3, and 8.5 respectively, suggesting a size of the coefficient next to labour productivity of   20 
around 0.5. However, if we look at the ‘long-difference’ estimation results, the estimated 
coefficient is around 0.4 for the sample of 14 EU, plus USA countries (Table 8.2), around 0.7 if 
we drop the first and the last observations of the whole sample period (Table 8.4), and around 
0.5 if we look at the full sample of countries, without France, Greece, and Italy (Table 8.6). 
Hence, we conclude that labour productivity in the economy as a whole has a large, positive and 
significant effect on health expenditures per capita. The estimated effect ranges from 0.4 to 0.7.   21 
5  Productivity growth in health care 
The estimation results presented in the previous section are consistent with a large Baumol 
effect in health spending. The Baumol effect arises because productivity growth in the economy 
as a whole translates into wage growth in all sectors of the economy, including the sectors that 
lag behind in productivity growth (Baumol and Bowen (1966)). This raises relative prices in 
these lagging sectors. If demand is inelastic, this will result in a rise in real spending on goods 
and services produced in lagging sectors. This seems to apply to health care in the panel of 
countries included in our analysis.  
In order to determine by how much labour productivity growth in health care lags behind 
overall productivity growth, we employ equations (8) – (10). For this calculation, we use the 
estimate for δ presented in the final column of Table 4.2. We also need information on the 
labour share of health care and on the price elasticity of demand for health.  
Data on the labour share in health care are not readily available. However, the Groningen 
Growth and Development Centre (GGDC) maintains an Industry Growth Accounting Database 
which contains data on the labour share in various sectors of the economy for Australia, 
Canada, France, Germany, the Netherlands, the United Kingdom and the United States.
9 One of 
the sectors covered by the database is non-market services, which includes most of health 
care.
10 According to these data, the labour share of non-market services is about 0.8. We will 
take this as our central estimate and perform sensitivity analysis using 0.7 and 0.9. 
Estimates for the price elasticity of demand for health from the literature have recently been 
surveyed in Ringel et al. (2002). The authors summarize their findings as follows: “Despite a 
wide variety of empirical methods and data sources, the estimates of the demand for health care 
[..] are consistently found to be price inelastic. Although the range of price elasticity estimates 
is relatively wide, it tends to centre on –0.17, meaning that a one percent increase in the price of 
health care will lead to 0.17 percent reduction in health care expenditures.” (Ringel et al. 
(2002), p. 20). We will use –0.2 as our central estimate and again perform sensitivity analysis 
around this value.  
Calibration results are presented in Table 5.1. According to our central estimate 
corresponding to a labour share of 0.8 and a price elasticity of demand of –0.2, labour 
productivity in health care was 20% of labour productivity in the overall economy. Moreover, 
this value does not differ significantly from zero. Sensitivity analyses around these values 
indicate that this conclusion remains valid for other values of the parameters, except for the 
 
9 The database can be accessed at www.ggdc.net. 
10 According to the OECD national accounts definition, non-market services include general public services, non-market 
services of education and research provided by general government and private non-profit institutions, non-market services 
of  health  provided  by  general  government  and  private  non-profit  institutions,  domestic  services  and  other  non-market 
services n.e.c. (http://stats.oecd.org/glossary/detail.asp?ID=1814).   22 
combination of very low demand elasticities and a very high labour share. In this case, labour 
productivity in health care amounts to 40% of labour productivity in the overall economy, and it 
is statistically significantly different from zero. 
Table 5.1  Labour productivity in health care as a fraction of labour productivity in the overall economy 
Demand elasticity     Labour share                                                       
       
  0.7  0.8  0.9 
       
− 0.1  0.2  0.3  0.4 
  (0.9)  (1.6)  (2.2) 
− 0.2  0.1  0.2  0.3 
  (0.4)  (1.0)  (1.6) 
− 0.3  0  0.1  0.2 
  (− 0.1)  (0.4)  (0.9) 
 
Note: based on equations 6-8, using the estimated coefficients in the final column of Table 4.2; t-values in parentheses. 
 
The findings reported in Table 5.1 may be compared with recent quality-adjusted estimates of 
medical productivity in the US reported in Triplett ad Bosworth (2003). They find for the US 
that labour productivity in health services rose by 0.7 percent per year in the period 1995-2000, 
a sharp break with the measured fall in labour productivity in health care in the years before 
1995. They argue that this break reflects improved measured methods rather than a real change 
in productivity. For the whole (non-farm) US-economy they report 2.6% annual labour 
productivity growth. Thus, labour productivity in health care rose 0.27 times as rapid as labour 
productivity in the economy as a whole. This is quite consistent with the values in Table 5.1 
that correspond to low a price elasticity of demand and/or a high labour share.   23 
6  Conclusions 
In this paper, we study the Baumol effect in health spending, using a panel data set of OECD 
countries. We try to answer two questions: 
 
1.  How large is the Baumol effect in health care? 
2.  What does the estimated Baumol effect say about the amount cost-reducing technological 
change in health care? 
 
We address the first question by regressing real health spending on real income and overall 
productivity growth in the economy as measured by the real GDP per hour worked. We find 
large effects of labour productivity growth in the overall economy on real health spending. One 
percentage growth in economy-wide labour productivity is associated to with about 0.5 percent 
growth in real health spending. As far as we know, this is a novel empirical finding. The 
implication of this finding is that the Baumol effect is important, a conclusion that agrees with 
recent research by Nordhaus (2006) for other sectors of the economy.  
In order to answer the second question, we interpret the estimated Baumol effect as a 
reduced form coefficient of a structural model in which real health spending is determined by 
the relative price per unit of health care of constant quality, the price elasticity of demand, 
income per capita and demographic shifters. We assume that the relative price per unit of health 
care of constant quality is solely determined by the Baumol effect. We find that labour 
productivity in health care was about one fifth as high a labour productivity in the overall 
economy.  
It should be noted that our regression design is very simple. Extensions of the empirical 
approach would include testing for the nonstationarity of the analysed series and performing 
panel data unit root and cointegration tests (for more details, see Verbeek (2004), chapter 10.6). 
It would also be interesting to estimate multivariate unobserved components model, where 
technology progress would be modelled as an unobserved state variable. For an application of 
this approach to the financial data, see Menkveld, Koopman and Lucas (2007).   24   25 
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Appendix 
A1  Robustness checks 
A1.1  Estimation results for a smaller sample of countries (14 EU countries, plus USA) 
 
Table A1.1  Estimates of equation (11): all available years 
Variable  FE (1)  FE (2)  FD (3)  FD (4) 
    (robust SEs)    (robust SEs) 
         
lgdph  0.176  0.176     
  (0.082)**  (0.298)     
lgdp
2
  1.028  1.028     
  (0.089)***  (0.368)**     
lpop  0.868  0.868     
  (0.079)***  (0.323)**     
dlgdph      0.565  0.565 
      (0.111)***  (0.175)*** 
dlgdp
2
      0.450  0.450 
      (0.110)***  (0.144)*** 
dlpop      0.742  0.742 
      (0.152)***  (0.162)*** 
         
Observations  449  449  427  427 
Number of countries  15  15     
         
Note: he = health expenditures per capita; gdph = GDP per hour worked; gdp = GDP per capita (gdp
2
 = GGDC source); pop = population 








Table A1.2  Estimates of equation (12): 'long-difference' estimation procedure 
Variable  LD (1)  LD (2)  LD (3) 
       
  1970, 1987;   1970, 1979;  five-year periods 
  1988, 2004  1980, 1989;  1970, 1974; 
    1990, 1999; etc.   1975, 1979; etc. 
       
lgdph  0.369  0.431  0.334 
  (0.319)  (0.319)  (0.168)* 
lgdp
2
  1.063  1.069  1.025 
  (0.368)**  (0.354)***  (0.173)*** 
lpop  0.543  0.328  0.168 
  (0.357)  (0.296)  (0.265) 
       
Observations  20  47  83 
 
Note: he = health expenditures per capita; gdph = GDP per hour worked; gdp = GDP per capita (gdp
2
 = GGDC source); pop = population 
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A1.2  Estimation results for a shorter sample period, that is, without the first and the  
  last observations of the sample period (t = 1970 and t = 2004, respectively) 
 
Table A1.3  Estimates of equation (11): all available years, less 1970 & 2004 
Variable  FE (1)  FE (2)  FD (3)  FD (4) 
    (robust SEs)    (robust SEs) 
         
lgdph  0.147  0.147     
  (0.072)**  (0.201)     
lgdp
2
  1.209  1.209     
  (0.074)***  (0.259)***     
lpop  0.483  0.483     
  (0.053)***  (0.279)*     
         
dlgdph      0.487  0.487 
         
      (0.098)***  (0.160)*** 
dlgdp
2
      0.404  0.404 
      (0.094)***  (0.120)*** 
dlpop      0.825  0.825 
      (0.127)***  (0.149)*** 
         
Observations  691  691  663  663 
Number of countries  23  23     
 
Note: he = health expenditures per capita; gdph = GDP per hour worked; gdp = GDP per capita (gdp
2
 = GGDC source); pop = population 








Table A1.4  Estimates of equation (12): 'long-difference' estimation procedure 
Variable  LD (1)  LD (2)  LD (3) 
       
  1971, 1986;   1971, 1981;  Five-year periods 
  1987, 2003  1982, 1992;  1971, 1975; 
    1993, 2003   1976, 1980; etc. 
       
lgdph  0.282  0.747  0.753 
  (0.237)  (0.212)***  (0.180)*** 
lgdp
2
  1.246  0.757  0.620 
  (0.253)***  (0.206)***  (0.174)*** 
lpop  0.365  0.350  0.378 
  (0.218)  (0.200)*  (0.219)* 
       
Observations  38  60  143 
       
Note: he = health expenditures per capita; gdph = GDP per hour worked; gdp = GDP per capita (gdp
2
 = GGDC source); pop = population 
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A1.3  Estimation results for a smaller sample of countries (without France, Greece, and  
  Italy) 
 
Table A1.5  Estimates of equation (11): all available years 
Variable  FE (1)  FE (2)  FD (3)  FD (4) 
    (robust SEs)    (robust SEs) 
         
lgdph  0.165  0.165     
  (0.074)**  (0.213)     
lgdp
2
  1.227  1.227     
  (0.075)***  (0.282)***     
lpop  0.465  0.465     
  (0.054)***  (0.285)     
         
dlgdph      0.541  0.541 
      (0.100)***  (0.160)*** 
dlgdp
2
      0.424  0.424 
      (0.096)***  (0.132)*** 
dlpop      0.765  0.765 
      (0.131)***  (0.146)*** 
         
Observations  670  670  649  649 
Number of countries  20  20     
         
Note: he = health expenditures per capita; gdph = GDP per hour worked; gdp = GDP per capita (gdp
2
 = GGDC source); pop = population 








Table A1.6  Estimates of equation (12): 'long-difference' estimation procedure 
Variable  LD (1)  LD (2)  LD (3) 
       
  1970, 1987;   1970, 1979;  five-year periods 
  1988, 2004  1980, 1989;  1970, 1974; 
    1990, 1999; etc.   1975, 1979; etc. 
       
lgdph  0.348  0.643  0.468 
  (0.259)  (0.262)**  (0.141)*** 
lgdp
2
  1.241  0.868  0.964 
  (0.281)***  (0.272)***  (0.140)*** 
lpop  0.398  0.331  0.091 
  (0.265)  (0.221)  (0.192) 
       
Observations  30  69  127 
       
Note: he = health expenditures per capita; gdph = GDP per hour worked; gdp = GDP per capita (gdp
2
 = GGDC source); pop = population 
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A2  Graphs 
Figure A2.1  GDP p/c from the two data sources (OECD & GGDC) 
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Figure A2.1  Continued 
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Figure A2.2  Total health expenditures p/c series, expressed in the 2006 US dollars,  
    converted to 2006 price level with updates 2002 EKS PPPs 
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Figure A2.2  Continued 
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